Clinical trial

Masitinib in Patients With Mild Alzheimer's Disease

NCT05564169

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhasePHASE3

Study timeline

Study start (estimated)2026-06-01Date precision: month

Registry last updated2025-10-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

PlaceboDRUG

Masitinib (4.5)DRUG

Standard of careDRUG

Sponsors & collaborators

AB Sciencelead sponsor

Mapped research locations

MadridSpain1 BarcelonaSpain1 ParisFrance1 GranadaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05564169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.